Your session is about to expire
← Back to Search
APRETUDE for HIV Prevention (EBONI Trial)
EBONI Trial Summary
This trial studies how well a drug called Cabotegravir works to prevent HIV infection, and how easy it is to give to people in a clinical setting. It looks at two types of participants: those receiving the drug, and those administering it.
EBONI Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.EBONI Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am a female by birth or identify as a transgender female.I am 18 years old or older.I have never received CAB treatments.I identify as a cisgender or transgender male.I have never taken oral CAB or received CAB LA injections.My doctor agrees that CAB PrEP is suitable for me according to its prescription guidelines.I am able to understand and sign the consent form.I am a female by birth or identify as a transgender female.I am 18 years old or older.You have identified yourself as a person of African American or Black ethnicity.
- Group 1: Enhanced Collaborative Implementation (ECI)
- Group 2: Standard Implementation (SI)
- Group 3: Enhanced Implementation (EI)
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the FDA sanctioned Enhanced Implementation (EI) as a valid treatment?
"The safety of Enhanced Implementation (EI) is rated as a 3, since this therapy has been approved by the relevant authority. This signifies that it is in Phase 4 clinical trials."
Is this research initiative presently accepting participants?
"Affirmative. According to clinicaltrials.gov, this medical trial is recruiting participants at 8 sites since its original post on October 31st 2022 and last update on November 17th 2022. The study aims to recruit 250 individuals in total."
How many participants have been accepted into this research endeavor?
"Affirmative. According to the information on clinicaltrials.gov, this medical trial is still looking for enrollees and was initially posted on October 31st 2022. As of November 17th 2022, 250 applicants are needed from 8 different healthcare centres."
How many locations are participating in this trial?
"Currently, 8 clinical trial sites are engaging patients in this study. The locations span from Tampa to West Palm Beach and Norfolk to other distant locales. To reduce the need for travel, it is beneficial to select the closest location when considering participation."
Who else is applying?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What state do they live in?
What site did they apply to?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger